Form 4: Johnson & Johnson Executive John C. Reed Reports Stock Option and Restricted Share Unit Awards

Sentiment:

SEC Form 4 Filing


EVP John C. Reed reports acquisition of stock options and restricted share units in Johnson & Johnson under the company's Long-Term Incentive Plan.

Summary

  • John C. Reed, an Executive Vice President at Johnson & Johnson, filed a Form 4 to report changes in beneficial ownership of company securities.
  • On February 15, 2025, Reed was awarded 89,781 employee stock options with an exercise price of $156.15.
  • These options vest in three equal annual installments starting on the first anniversary of the grant date and expire on 02/15/2035.
  • Reed also received 5,539 restricted share units (RSUs) that vest in three equal annual installments beginning on the first anniversary of the grant date.
  • The RSUs convert into shares of common stock on a one-for-one basis upon vesting.
  • Following these transactions, Reed directly owns 89,781 stock options and 5,539 RSUs.

Sentiment

Score: 7

Explanation: The document reflects a routine executive compensation event, which is generally viewed neutrally to positively as it incentivizes management. The sentiment is moderately positive.

Positives

  • The grant of stock options and RSUs aligns Reed's interests with those of Johnson & Johnson shareholders.
  • The vesting schedule encourages long-term commitment from the executive.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule of the options and RSUs suggests a multi-year horizon for executive compensation.

Industry Context

Executive compensation packages often include stock options and restricted share units to incentivize performance and align executive interests with shareholder value. This filing reflects a standard practice in publicly traded companies.

Stakeholder Impact

  • Shareholders may view the equity-based compensation as a positive incentive for management to drive long-term value.
  • Employees may see the executive compensation as a reflection of the company's commitment to rewarding leadership.

Key Dates

DateDescription
02/15/2025Date of stock option and RSU awards.
02/15/2025Stock options exercisable date.
02/15/2035Stock options expiration date.
02/19/2025Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.